Subscribe

Retinoic Acid Syndrome | Acute Promyelocytic Leukemia

Purpose:

To determine if a patient with acute promyelocytic leukemia (APML) treated with trans-retinoic acid has the retinoic acid syndrome.

Specialty:

Hematology Oncology

Objective:

adverse effects

ICD-10:

T49.0

Description:

Trans-retinoic acid (tretinoin) is used to treat patients with Acute Promyelocytic Leukemia. The Retinoic Acid Syndrome is an acute syndrome which may occur shortly after the trans-retinoic acid therapy is started. If untreated this is a serious condition which can be fatal.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone